Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.00 (-0.10%)
Close on Nov 18, 2026Market cap $41.52MP/E –Yield –
Talphera net income
Net income is the profit left for shareholders after every expense, interest and tax.
Talphera's net income for the twelve months ending Jun 30, 2026 was -$15.08M. For fiscal 2025 it was -$14.29M. The highest annual figure on record is $47.76M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.29M | – |
| FY2024 | Dec 31, 2024 | -$13.00M | – |
| FY2023 | Dec 31, 2023 | -$18.40M | -138.5% |
| FY2022 | Dec 31, 2022 | $47.76M | – |
| FY2021 | Dec 31, 2021 | -$35.10M | – |
| FY2020 | Dec 31, 2020 | -$40.38M | – |
| FY2019 | Dec 31, 2019 | -$53.24M | – |
| FY2018 | Dec 31, 2018 | -$47.15M | – |
| FY2017 | Dec 31, 2017 | -$51.51M | – |
| FY2016 | Dec 31, 2016 | -$43.16M | – |
| FY2015 | Dec 31, 2015 | -$24.40M | – |
| FY2014 | Dec 31, 2014 | -$33.35M | – |
| FY2013 | Dec 31, 2013 | -$23.43M | – |
| FY2012 | Dec 31, 2012 | -$33.36M | – |
| FY2011 | Dec 31, 2011 | -$20.10M | – |
| FY2010 | Dec 31, 2010 | -$14.34M | – |
| FY2009 | Dec 31, 2009 | -$20.12M | – |
| FY2008 | Dec 31, 2008 | -$20.66M | – |
| FY2007 | Dec 31, 2007 | -$9.63M | – |
| FY2006 | Dec 31, 2006 | -$3.77M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.31M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.56M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.49M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.87M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.35M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.52M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.36M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.37M | -106.2% |
| Q1 FY2023 | Mar 31, 2023 | -$8.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.48M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.75M | – |
| Q2 FY2022 | Jun 30, 2022 | $70.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.67M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.38M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.92M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.93M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.61M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.93M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$12.73M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.41M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$12.56M | – |
| Q3 FY2018 | Sep 30, 2018 | -$12.46M | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.54M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.59M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.89M | – |
| Q3 FY2017 | Sep 30, 2017 | -$13.01M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.06M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.55M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.68M | – |
| Q3 FY2016 | Sep 30, 2016 | -$11.40M | – |
See a number that looks wrong?